CHF48.1 B

Roche Revenue FY, 2015
Roche Revenue growth (FY, 2014 - FY, 2015), %1%
Roche Gross profit (FY, 2015)32.7 B
Roche Gross profit margin (FY, 2015), %67.9%
Roche Net income (FY, 2015)9.1 B

Roche Revenue

Roche revenue was CHF48.15 b in FY, 2015 which is a 1.4% year over year increase from the previous period.

Embed Graph

Roche Revenue Breakdown

Embed Graph

Roche revenue breakdown by business segment: 77.5% from Pharmaceuticals and 22.5% from Diagnostics

Roche Income Statement

Annual

CHFFY, 2013FY, 2014FY, 2015

Revenue

46.8b47.5b48.1b

Revenue growth, %

1%1%

Cost of goods sold

11.9b13.4b15.5b

Gross profit

34.8b34.1b32.7b

Gross profit Margin, %

74%72%68%

Sales and marketing expense

8.4b8.7b8.8b

R&D expense

9.3b9.9b9.6b

General and administrative expense

2.6b3.8b2.7b

Operating expense total

20.3b22.4b21.1b

Interest expense

1.6b1.8b1.6b

Interest income

119.0m246.0m260.0m

Income tax expense

(3.3b)(3.0b)(2.9b)

Net Income

11.4b9.5b9.1b

Roche Cash Flow

Annual

CHFFY, 2013FY, 2014FY, 2015

Cash From Operating Activities

15.8b15.9b15.3b
Report incorrect company information

Roche Operating Metrics

Y, 2014Y, 2015Y, 2016

Drugs Approved by FDA

2

Major Approvals (US, EU, JP)

5 12

US FDA Breakthrough Therapy Designations

3 4 5
Report incorrect company information